+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Latex Agglutination Test Kits"

From
Latex Agglutination Test Kits Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Latex Agglutination Test Kits Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 143 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

In the field of clinical diagnostics, latex agglutination test kits represent a rapid, convenient method for detecting the presence of specific antigens or antibodies in a sample, often related to infectious diseases, autoimmune disorders, and other medical conditions. These tests involve the use of latex beads coated with an antigen or antibody. When a sample containing the target substance is added, it binds to the coating, causing the beads to clump, or agglutinate. This agglutination can be visually observed, providing a qualitative or semi-quantitative result. Enzymes play a crucial role in enhancing these tests. They are sometimes conjugated to the antibodies or antigens on the latex beads, amplifying the agglutination reaction and thereby improving the sensitivity and specificity of the test. Such enzyme-enhanced assays are particularly useful where high accuracy is essential, such as in the diagnosis of certain diseases or the detection of minute antibody titers. Many companies operate in the market for latex agglutination test kits. Some well-renowned providers include Thermo Fisher Scientific, which offers a wide range of diagnostic solutions; Becton, Dickinson and Company, known for their medical devices and laboratory equipment; Merck KGaA, with a diversified portfolio including life sciences and healthcare; and Abbott, which develops medical devices and healthcare products. These companies, along with others such as Bio-Rad Laboratories and Cardinal Health, contribute to the availability and advancement of latex agglutination test technologies. Show Less Read more